Austar Lifesciences Limited AULSF
AULSF Rating
AULSF Rating Factors
AULSF Company Overview
Austar Lifesciences Limited (HKEX: 6118; OTC: AULSF) is a China-based pharmaceutical engineering and life sciences solutions company focused on serving the biotechnology, pharmaceutical, and healthcare manufacturing industries. The company provides integrated engineering services, cleanroom and process solutions, manufacturing equipment, and digitalized production technologies for pharmaceutical and biotech facilities. Its operations are closely tied to the growth of China’s biopharmaceutical manufacturing sector, including sterile injectables, biologics, cell and gene therapy, and related high-specification production environments.
The company’s principal revenue drivers include engineering, procurement, and construction-related services for pharmaceutical production facilities; clean utility and process systems; aseptic and containment technologies; and equipment distribution and validation services. Austar Lifesciences evolved from a pharmaceutical engineering and cleanroom systems provider into a broader life sciences technology platform with capabilities spanning facility design, automation, compliance support, and intelligent manufacturing systems. Public filings and corporate disclosures consistently position the company as a specialized provider focused on regulatory-compliant pharmaceutical manufacturing infrastructure and process optimization.
AULSF Income Statement
AULSF Balance Sheet
AULSF Price History
- Current
- $0.02
AULSF Valuation
AULSF Dividends and Shares
AULSF Corporate Info
Rooms 2010-2013, 20th Floor
Changning District
Shanghai,